Evidence map›Paper›PMID 35905049›Full record

ArticlePloS one2022

Low risk of acquiring melioidosis from the environment in the continental United States.

Carina M Hall, Daniel Romero-Alvarez, Madison Martz, Ella Santana-Propper, Lora Versluis, Laura Jiménez, Abdelghafar Alkishe, Joseph D Busch, Trevor Maness, Jonathan Stewart and 10 more

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Carina M HallPathogen Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America.ORCID 0000-0001-6941-3207
Daniel Romero-AlvarezUniversity of Kansas, Lawrence, Kansas, United States of America.ORCID 0000-0002-6762-6046
Madison MartzPathogen Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America.
Ella Santana-PropperPathogen Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America.
Lora VersluisPathogen Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America.
Laura JiménezUniversity of Kansas, Lawrence, Kansas, United States of America.ORCID 0000-0002-6683-9576
Abdelghafar AlkisheUniversity of Kansas, Lawrence, Kansas, United States of America.
Joseph D BuschPathogen Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America.
Trevor ManessTexas Department of State Health Services, San Antonio, Texas, United States of America.
Jonathan StewartTexas Department of State Health Services, San Antonio, Texas, United States of America.
Tom SidwaTexas Department of State Health Services, Austin, Texas, United States of America.
Jay E GeeCenters for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Mindy G ElrodCenters for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Zachary WeinerCenters for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Alex R HoffmasterCenters for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Jason W SahlPathogen Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America.
Johanna S SalzerCenters for Disease Control and Prevention, Atlanta, Georgia, United States of America.
A Townsend PetersonUniversity of Kansas, Lawrence, Kansas, United States of America.
Amanda KiefferTexas Department of State Health Services, San Antonio, Texas, United States of America.
David M WagnerPathogen Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America.ORCID 0000-0003-2684-6007

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melioidosis is an underreported human disease of tropical and sub-tropical regions caused by the saprophyte Burkholderia pseudomallei. Although most global melioidosis cases are reported from tropical regions in Southeast Asia and northern Australia, there are multiple occurrences from sub-tropical regions, including the United States (U.S.). Most melioidosis cases reported from the continental U.S. are the result of acquiring the disease during travel to endemic regions or from contaminated imported materials. Only two human melioidosis cases from the continental U.S. have likely acquired B. pseudomallei directly from local environments and these cases lived only ~7 km from each other in rural Texas. In this study, we assessed the risk of acquiring melioidosis from the environment within the continental U.S. by surveying for B. pseudomallei in the environment in Texas where these two human melioidosis cases likely acquired their infections. We sampled the environment near the homes of the two cases and at additional sampling locations in surrounding counties in Texas that were selected based on ecological niche modeling. B. pseudomallei was not detected at the residences of these two cases or in the surrounding region. These negative data are important to demonstrate that B. pseudomallei is rare in the environment in the U.S. even at locations where locally acquired human cases likely have occurred, documenting the low risk of acquiring B. pseudomallei infection from the environment in the continental U.S.

Indexed as

Burkholderia pseudomalleiMelioidosisAustraliaHumansTexasTravelUnited States

Identifiers

PMID35905049
PMCPMC9337633

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.